Systems pharmacology integrates principles derived from pharmacology, bioinformatics, and systems biology to comprehensively elucidate the intricate interactions occurring between drugs and biological systems. This interdisciplinary field employs a systematic analysis of drug effects across molecular, cellular, tissue, and organism levels, taking into account the interconnected networks of genes, proteins, and pathways. Through the utilization of computational models, cheminformatics, and high-throughput data, systems pharmacology aims to predict drug responses, discern potential off-target effects, and optimize therapeutic outcomes. This approach acknowledges the dynamic and adaptive nature of biological systems, providing a more precise representation of drug behavior in vivo. By integrating pharmacoepidemiology and pharmacovigilance data, systems pharmacology enhances our understanding of real-world drug utilization patterns and safety profiles. In essence, systems pharmacology not only transcends traditional reductionist approaches but also represents a paradigm shift towards a more holistic and data-driven era in pharmacological research. This integrative approach fosters a deeper exploration of pharmacotherapeutic strategies, emphasizing the importance of personalized medicine, polypharmacy considerations, and the optimization of drug combinations to address the complexities of diverse patient populations.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia